Your browser doesn't support javascript.
loading
Sleepless and Spent in Survivorship: Fatigue and Insomnia in Breast Cancer Survivors.
Boldyrev, Laura; Ghebremichael, Musie S; Lotz, Margaret M; Kovarie, Gabrielle; Kennedy, Kelly; Keates, Sarah; Pories, Susan E.
Afiliação
  • Boldyrev L; Hoffman Breast Center, Department of Surgery, RinggoldID:14319Mount Auburn Hospital, Cambridge, MA, USA.
  • Ghebremichael MS; RinggoldID:200750The Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
  • Lotz MM; Harvard Medical School, Boston, MA, USA.
  • Kovarie G; Hoffman Breast Center, Department of Surgery, RinggoldID:14319Mount Auburn Hospital, Cambridge, MA, USA.
  • Kennedy K; Harvard Medical School, Boston, MA, USA.
  • Keates S; Hoffman Breast Center, Department of Surgery, RinggoldID:14319Mount Auburn Hospital, Cambridge, MA, USA.
  • Pories SE; Hoffman Breast Center, Department of Surgery, RinggoldID:14319Mount Auburn Hospital, Cambridge, MA, USA.
Am Surg ; 88(11): 2730-2736, 2022 Nov.
Article em En | MEDLINE | ID: mdl-35282702
BACKGROUND: It is estimated that there are 3.8 million breast cancer survivors in the United States. Addressing survivors' post-treatment needs is critical to providing quality healthcare. METHODS: A standardized questionnaire for breast cancer survivors was employed to assess the health status, challenges, and concerns of our breast cancer patients at their survivorship visits, which were conducted 4 months after surgery. All patients were seen in the breast center at one community hospital over a 6-year period. RESULTS: Responses to a standardized questionnaire that was administered to 505 consecutive breast cancer patients at their survivorship visits 4 months after surgery were evaluated. The most striking finding was that 35% reported symptoms of insomnia, 26% had persistent fatigue, and 19% experienced fatigue that interfered with their usual activities. There was a significant association between symptoms of insomnia and radiation treatment (P = .004), pain (P < .001), hormone therapy (P < .01), and side effects of hormone therapy (P < .0001). There was also a significant association between fatigue and pain (P < .001) as well as side effects from hormone treatment (P = .0036). CONCLUSIONS: Over a third (35%) of breast cancer patients suffer from insomnia, while over a quarter (26%) complain of fatigue at their survivorship assessments. Contributing factors include radiation treatment, pain, and hormonal therapy. Careful assessment and treatment of fatigue and symptoms of insomnia in breast cancer patients is needed to improve quality of life for survivors.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Sobreviventes de Câncer / Distúrbios do Início e da Manutenção do Sono Tipo de estudo: Etiology_studies Aspecto: Patient_preference Limite: Female / Humans Idioma: En Revista: Am Surg Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Sobreviventes de Câncer / Distúrbios do Início e da Manutenção do Sono Tipo de estudo: Etiology_studies Aspecto: Patient_preference Limite: Female / Humans Idioma: En Revista: Am Surg Ano de publicação: 2022 Tipo de documento: Article